Novartis to Buy Bristol-Myers' Nutrition Business

According to a Reuters story, Swiss healthcare group Novartis said it would buy the worldwide adult medical nutrition business of Mead Johnson & Co, a unit of Bristol-Myers Squibb Co. for $385 million in cash.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.